# Hackathon Plan: "BioCure Swarm"

This plan outlines the architecture, UX details, multi-agent scientific swarm integration, and launch strategy for building **BioCure Swarm** during the Cerebras x Google Gemma 4 Hackathon.

---

## 1. Technical Architecture & UX Guidelines

To showcase the power of the Cerebras Wafer-Scale CS-3 engine, the user experience must highlight the contrast between traditional sequential GPU latency and Cerebras speed.

```
┌────────────────────────────────────────────────────────┐
│                      BIOCURE SWARM                     │
├───────────────────────────┬────────────────────────────┤
│ ⌨️ Scientific Query       │ 🧬 Spatial Evidence Viewer  │
│                           │ (3D protein structure view)│
│ > "Protein folding for.." │                            │
│                           ├────────────────────────────┤
│ Agent Swarm Stream...     │ 📜 Scientific Report       │
│ [ 1,450 tokens/sec ]      │ (Detailed synthesis plan)  │
└───────────────────────────┴────────────────────────────┘
```

### High-fidelity UX Features:
* **Interactive 3D Molecular Canvas:** Instantly load and render interactive 3D protein structures (using `3Dmol.js`) tailored to the user's scientific target.
* **Agent Swarm Stream:** Show the active logs from the 4 expert agents (Sequence Analyst, Folding Predictor, Literature Cross-Referencer, Synthesis Optimizer) as they execute in parallel.
* **Real-time Showdown HUD:** Track inference speed (tok/s), latency, and comparative savings between Cerebras and a standard GPU cluster.

---

## 2. Multi-Agent Swarm Details

We implement a chained 4-agent workflow:
1. **Sequence Analyst**: Performs sequence anomaly and motif discovery.
2. **Folding Predictor**: Hypothesizes the 3D folding pattern and stability.
3. **Literature Cross-Referencer**: Highlights biological correlations and PubMed references.
4. **Synthesis Optimizer**: Generates the final chemical lab protocol.

---

## 3. Prize Category Alignment
- **Multiverse Agents**: Uses 4 distinct expert agents in a collaborative pipeline.
- **Enterprise Impact**: Directly targets the multi-billion dollar Drug Discovery and Personalized Medicine market.
- **People's Choice**: High-end visual aesthetics (3D molecular structures) designed for virality.
